Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1980 1
1990 1
1992 1
1993 1
1994 1
1996 3
1998 2
1999 1
2000 3
2001 2
2002 2
2004 5
2005 1
2006 3
2007 4
2008 1
2009 5
2010 3
2011 5
2012 6
2013 9
2014 7
2015 12
2016 7
2017 9
2018 12
2019 7
2020 7
2021 5
2022 9
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML; Endocrine Society. Thakker RV, et al. J Clin Endocrinol Metab. 2012 Sep;97(9):2990-3011. doi: 10.1210/jc.2012-1230. Epub 2012 Jun 20. J Clin Endocrinol Metab. 2012. PMID: 22723327 Review.
MEN1 is characterized by the occurrence of parathyroid, pancreatic islet, and anterior pituitary tumors. Some patients may also develop carcinoid tumors, adrenocortical tumors, meningiomas, facial angiofibromas, collagenomas, and lipomas. Patients with MEN1 h …
MEN1 is characterized by the occurrence of parathyroid, pancreatic islet, and anterior pituitary tumors. Some patients may also devel …
Targeting HER3 for cancer treatment: a new horizon for an old target.
Uliano J, Corvaja C, Curigliano G, Tarantino P. Uliano J, et al. ESMO Open. 2023 Feb;8(1):100790. doi: 10.1016/j.esmoop.2023.100790. Epub 2023 Feb 8. ESMO Open. 2023. PMID: 36764093 Free PMC article. Review.
Although its poor tyrosine kinase activity entails a weak oncogenic power on its own, HER3 can heterodimerize with HER2 and/or epidermal growth factor receptor (EGFR), leading to a drastic enhancement of transphosphorylation and activation of downstream signaling pathways, ultima …
Although its poor tyrosine kinase activity entails a weak oncogenic power on its own, HER3 can heterodimerize with HER2 and/or epidermal gro …
Surgical resection criteria and neoadjuvant therapies for intrahepatic cholangiocarcinoma.
O'Bryan J, Sadagopan N, Winslow E, Radkani P, Fishbein T, Banovac F, Cohen E, Hartley ML, He AR. O'Bryan J, et al. Clin Adv Hematol Oncol. 2023 Nov;21(11):584-591. Clin Adv Hematol Oncol. 2023. PMID: 37948594 Review.
Factors contributing to a higher stage of disease include larger tumor size, multiple tumors, vascular invasion (either portal venous or arterial), biliary invasion, involvement of local hepatic structures, serosal invasion, and regional lymph node metastases. ...Ad …
Factors contributing to a higher stage of disease include larger tumor size, multiple tumors, vascular invasion (either portal …
Management of Skin Cancer in the High-Risk Patient.
Behan JW, Sutton A, Wysong A. Behan JW, et al. Curr Treat Options Oncol. 2016 Dec;17(12):60. doi: 10.1007/s11864-016-0435-z. Curr Treat Options Oncol. 2016. PMID: 27766546 Review.
However, there is a subset of "high-risk" cases that prove challenging in terms of morbidity, mortality, adjuvant treatment required, as well as overall cost to the health care system. In our opinion, the term "high risk" when applied to skin cancer can mean one of three t …
However, there is a subset of "high-risk" cases that prove challenging in terms of morbidity, mortality, adjuvant treatment required, as wel …
Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study.
Chen YY, Guo WJ, Shi YF, Su F, Yu FH, Chen RA, Wang C, Liu JX, Luo J, Tan HY. Chen YY, et al. BMC Gastroenterol. 2023 Dec 14;23(1):440. doi: 10.1186/s12876-023-03079-6. BMC Gastroenterol. 2023. PMID: 38097952 Free PMC article.
BACKGROUND: Type 1 gastric neuroendocrine tumors (NETs) are relatively rare to the extent that some physicians have little experience in diagnosing and treating them. ...METHODS: The data of 229 patients (59.4% female) with type 1 gastric NETs who were treated at our cente …
BACKGROUND: Type 1 gastric neuroendocrine tumors (NETs) are relatively rare to the extent that some physicians have little experience …
HIFU for Palliative Treatment of Pancreatic Cancer.
Khokhlova TD, Hwang JH. Khokhlova TD, et al. Adv Exp Med Biol. 2016;880:83-95. doi: 10.1007/978-3-319-22536-4_5. Adv Exp Med Biol. 2016. PMID: 26486333 Review.
In the past decade, HIFU ablation has emerged as a modality for palliative treatment of pancreatic tumors. Multiple preclinical and non-randomized clinical trials have been performed to evaluate the safety and efficacy of this procedure. ...This chapter summarizes t …
In the past decade, HIFU ablation has emerged as a modality for palliative treatment of pancreatic tumors. Multiple preclinica …
Management of Hepatocellular Adenoma: Recent Advances.
Agrawal S, Agarwal S, Arnason T, Saini S, Belghiti J. Agrawal S, et al. Clin Gastroenterol Hepatol. 2015 Jul;13(7):1221-30. doi: 10.1016/j.cgh.2014.05.023. Epub 2014 Jun 5. Clin Gastroenterol Hepatol. 2015. PMID: 24909909 Review.
The inflammatory or telangiectatic subtype is at increased risk for hemorrhage, the beta-catenin-activated subtype is at increased risk for malignant transformation, and the hepatocyte nuclear factor-1alpha-inactivated or steatotic subtype is at the least risk for complications. …
The inflammatory or telangiectatic subtype is at increased risk for hemorrhage, the beta-catenin-activated subtype is at increased risk for …
Paragangliomas: etiology, presentation, and management.
Joynt KE, Moslehi JJ, Baughman KL. Joynt KE, et al. Cardiol Rev. 2009 Jul-Aug;17(4):159-64. doi: 10.1097/CRD.0b013e3181a6de40. Cardiol Rev. 2009. PMID: 19525677 Review.
Genetic testing should be offered to patients diagnosed with paraganglioma, particularly in patients who are young, have multiple tumors, or have a family history of malignancy. Management of paraganglioma is predicated on surgical resection, and careful perioperati …
Genetic testing should be offered to patients diagnosed with paraganglioma, particularly in patients who are young, have multiple …
Surgical treatment of hepatocellular carcinoma.
Hasegawa K, Kokudo N. Hasegawa K, et al. Surg Today. 2009;39(10):833-43. doi: 10.1007/s00595-008-4024-z. Epub 2009 Sep 27. Surg Today. 2009. PMID: 19784720 Review.
Surgical treatments, including liver resection and liver transplantation are, and will remain, the first-line therapeutic strategies for local control in patients with primary HCC. Although aggressive liver resection is often performed for advanced HCC in patients with a l …
Surgical treatments, including liver resection and liver transplantation are, and will remain, the first-line therapeutic strategies …
Management of multiple tumors in neurofibromatosis type 2 patients.
Aboukais R, Bonne NX, Baroncini M, Zairi F, Schapira S, Vincent C, Lejeune JP. Aboukais R, et al. Neurochirurgie. 2018 Nov;64(5):364-369. doi: 10.1016/j.neuchi.2014.11.012. Epub 2015 Jun 10. Neurochirurgie. 2018. PMID: 26071178
RESULTS: Intracranial meningiomas occur in 50% of NF2 patients, and are often multiple. Surgery remains the main treatment and should be performed in cases of growing tumors. ...Spinal tumors occur in about half of NF2 patients. Surgery should be discussed wh …
RESULTS: Intracranial meningiomas occur in 50% of NF2 patients, and are often multiple. Surgery remains the main treatment and should …
132 results